Cape Investment Advisory’s Boston Scientific BSX Stock Holding History

Cape Investment Advisory’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.9K	Buy	+68	New	+$3.69K	﹤0.01%	1159
2026 Q1	–	Sell	-98	Closed	-$9.34K	–	345
2025 Q4	$9.34K	Buy	98 +29	+42%	+$2.84K	﹤0.01%	771
2025 Q3	$6.74K	Buy	69 +10	+17%	+$1.04K	0.01%	470
2025 Q2	$6.34K	Buy	59 +34	+136%	+$3.44K	﹤0.01%	712
2025 Q1	$2.52K	Hold	25	–	–	﹤0.01%	860
2024 Q4	$2.23K	Buy	+25	New	+$2.2K	﹤0.01%	863
2024 Q1	–	Sell	-64	Closed	-$3.7K	–	956
2023 Q4	$3.7K	Buy	+64	New	+$3.42K	﹤0.01%	826

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Cape Investment Advisory's BSX Position: Q2 2026 in Review

Cape Investment Advisory opened a new position in Boston Scientific (BSX) in Q2 2026: 68 shares worth $2.9K. The stake represents ﹤0.01% of the portfolio and ranks #1159 among its holdings. This is a return to the name: Cape Investment Advisory previously reported a position in BSX as recently as Q4 2025.

Cape Investment Advisory first reported a position in BSX in Q4 2023 and has held it in 7 quarters since. The position peaked at $9.34K in Q4 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Cape Investment Advisory held 68 shares of Boston Scientific worth $2.9K as of Q2 2026.
Boston Scientific was a new Cape Investment Advisory position in Q2 2026.
Boston Scientific made up ﹤0.01% of Cape Investment Advisory's portfolio in Q2 2026, its #1159 holding.
Cape Investment Advisory first reported a position in Boston Scientific in Q4 2023 and has held it in 7 quarters since.
Cape Investment Advisory's Boston Scientific position peaked at $9.34K in Q4 2025.
1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Cape Investment Advisory's 13F filing for Q2 2026, filed 23 Jul 2026.